• Home
  • Blog
  • Preventing Life-Threatening Blood Clots in Children with Serious Cases of COVID-19

Preventing Life-Threatening Blood Clots in Children with Serious Cases of COVID-19

By Randolph Fillmore

Since the beginning of the COVID-19 pandemic, one of the most alarming and confounding aspects of the complex SARS-CoV-2 virus has been that people who become seriously ill with COVID-19, including children, are at increased risk for blood clots. The clots can appear in blood vessels both large and small, often with serious (and sometimes fatal) results.

The increased risk of blood clots (also called “thromboembolism”) appears to be related, at least in part, to the high levels of inflammation that the virus causes. The massive inflammatory response to COVID-19 can raise clotting factors in the blood and can cause blockage of blood vessels; when this occurs in arteries (which carry blood that nourishes healthy tissues with critical nutrients and oxygen). Deprived of oxygen, the tissue becomes injured or dies. In pediatric patients, the condition of high inflammation can affect tissues throughout the body — particularly the heart — and is called “multisystem inflammatory syndrome” (MIS-C).

Have a scientific story to share? Schedule a Consultation

Preventing COVID-19-related Blood Clots

Reducing the risk for blood clots is referred to in medical terms as “thromboprophylaxis,” which means using blood “thinners,” or anticoagulants (anti-clotting medications), to reduce the possibility of blood clots forming. Evidence regarding the safety and efficacy of using anticoagulants for thromboprophylaxis among pediatric patients hospitalized for COVID-19 has been limited—until recently, there have been no clinical trials performed that focused on this issue.

Read more:  Read the full story by Randy Fillmore

Related Stories:

Researchers Probe the New Frontier of Immune Therapy

Apples and Pears: Can Fat Distribution Patterns in Females Predict Health Problems?

Johns Hopkins All Children’s Study Provides Answers — and New Questions — about Treating a Serious Infection Affecting Mostly Children

Pandemic Impacts Pediatric Heart Transplants Nationwide

About Consonant Custom Media

Consonant Custom Media provides content marketing and storytelling for hospitals, health systems, nonprofits, foundations and life sciences innovators who want to make more meaningful connections with their communities of interest. We create original content that is truly consonant, or in harmony, with our clients' brand values and drives profitable consumer action.Clients use our original content strategically, to reach specific objectives in perception management, physician relations, service line development, sales and donor development. 

Schedule a Consultation

 


SHARE THIS POST

Consonant Custom Media
Real Stories. Real Engagement.

NYC

Mike Eisgrau
Dir. of Business Development

This email address is being protected from spambots. You need JavaScript enabled to view it.

Tampa Bay

Stephen A. Smith
Publisher | Creative Director 

This email address is being protected from spambots. You need JavaScript enabled to view it.

CA

John Wark
Consulting Editor | Dir. of Business Development

This email address is being protected from spambots. You need JavaScript enabled to view it.